Dr. Mikel Portu is a Medical Oncologist at the Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. His clinical work includes the management of thoracic and genitourinary malignancies, including lung cancer and renal cell carcinoma. His academic interests include genitourinary oncology, rare kidney cancer subtypes, precision oncology, and multidisciplinary cancer care.
Dr. Mario Balsa is a Resident Physician in Medical Oncology at the Medical Oncology Department, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain, where he is currently completing specialist training in Medical Oncology. His work focuses on the clinical management of solid tumors, with particular interest in genitourinary oncology and renal cell carcinoma. His interests include systemic therapies in kidney cancer, non-clear-cell renal cell carcinoma, melanoma and collaborative clinical research.
Dr. Maria Cotaina is a Resident Physician in Medical Oncology at the Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, where she is currently completing specialist training in Medical Oncology. Her clinical and academic activity focuses on solid tumors, with particular interest in renal cell carcinoma, precision oncology, and the integration of molecular pathology into therapeutic decision-making. Her interests include rare renal tumors, translational oncology, and multidisciplinary cancer management.
Dr. Georgia Anguera is a Medical Oncologist at the Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Her work includes the clinical care of patients with solid tumors and participation in collaborative research in genitourinary oncology, as well as phase I trials. Her interests include renal cell carcinoma, rare histologic subtypes, and the use of targeted therapy and immunotherapy in clinical practice.
Dr. Xavier García del Muro is a Medical Oncologist at the Medical Oncology Department, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain. He has extensive experience in the clinical management of solid tumors and in academic oncology research. His interests include renal cell carcinoma, treatment development in oncology, and the evaluation of systemic therapies in common and rare tumor subtypes.
Dr. Ferran Algaba is a Pathologist at the Pathology Department, Fundació Puigvert, Barcelona, Spain. His professional work focuses on urologic pathology, including the histopathologic and molecular characterization of renal neoplasms. His interests include rare renal tumor entities, immunohistochemistry, clinicopathologic correlation, and improving diagnostic precision in kidney cancer.
Dr. Pablo Maroto is a Medical Oncologist and current acting head of the Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. His clinical and academic work focuses on genitourinary malignancies and modern systemic treatment strategies. His interests include therapeutic advances in renal cell carcinoma, rare renal cancer subtypes, prostate cancer, urothelial tumors and translational research in oncology.
